What is the official ID of this bill?

The official print number for this legislation is S 606.

When did the legislative process begin?

The process officially started on 2023-03-01.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/118/bills/s606/BILLS-118s606is.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

Who is the primary sponsor?

The primary sponsor is Sen. Manchin, Joe, III [D-WV].

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Analysis and Potential Impact of S 606

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Opioid Drug Cap: Revoking One Approval for Every New Opioid Approved.

Q: What are the main provisions?

Key points include: Requires the FDA to revoke approval for one existing opioid drug for every new opioid drug approved. Prioritizes the removal of older opioid formulations that do not have abuse-deterrent features. The goal is to reduce the overall supply and risk associated with powerful prescription painkillers.

This bill aims to combat the opioid crisis by strictly limiting the number of prescription opioid drugs available. For every new opioid pain medication the FDA approves, the agency must revoke the approval of an existing one. This measure prioritizes removing older, less safe drugs that lack features designed to prevent abuse, thereby enhancing public safety.

Key points

Requires the FDA to revoke approval for one existing opioid drug for every new opioid drug approved.

Prioritizes the removal of older opioid formulations that do not have abuse-deterrent features.

The goal is to reduce the overall supply and risk associated with powerful prescription painkillers.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

Protecting Americans from Dangerous Opioids Act

Print number: S 606

Sponsor: Sen. Manchin, Joe, III [D-WV]

Process start date: 2023-03-01

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-flash-latest

Source data: api.congress.gov

AI work logs for this document launch

Opioid Drug Cap: Revoking One Approval for Every New Opioid Approved.

Key Questions about Opioid Drug Cap: Revoking One Approval for Every New Opioid Approved.